Prevention of ischaemia-induced coronary vascular dysfunction

International Journal of Cardiology

Volumn 62, Issue SUPPL. 2, 1997, Pages

  Woodman, Owen L ^a   Hart, Joanne L ^a   Sobey, Christopher G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Amlodipine; Endothelium; Polymorphonuclear leukocytes; Vasoconstriction

Indexed keywords

ACETYLCHOLINE; AMLODIPINE; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; GLYCERYL TRINITRATE; PHENTOLAMINE; PROPRANOLOL; VASODILATOR AGENT;

ANIMAL TISSUE; CELL INTERACTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DOG; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HEART MUSCLE REPERFUSION; ISCHEMIC HEART DISEASE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD FLOW VELOCITY; CALCIUM CHANNEL BLOCKERS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOGS; ENDOTHELIUM, VASCULAR; FEMALE; MALE; MICROSCOPY, ELECTRON; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NEUTROPHILS; RABBITS; VASOCONSTRICTION;

EID: 0031593042     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00246-5     Document Type: Conference Paper

References (34)

1. Gorman M.W., Sparks H.V. Progressive coronary vasoconstriction during relative ischaemia in canine myocardium. Circ Res. 51:1982;411-420.
2. Chu A., Chambers D.E., Lin C.C., Kuehl W.D., Cobb F.R. Ischaemia-induced epicardial vasoconstriction; a potential mechanism for distant myocardial ischaemia. Circ Res. 66:1990;1484-1490.
3. Meredith I.T., Yeung A.C., Weidinger F.F.et al. Role of impaired endothelium-dependent vasodilation in ischemic manifestations of coronary artery disease. Circulation. 87(Suppl V):1993;V56-V66.
4. Sobey C.G., Woodman O.L. Myocardial ischaemia: what happens to the coronary arteries? Trends Pharmacol Sci. 14:1993;448-453.
5. Welbourn C.R.B., Goldman G., Paterson I.S., Valeri C.R., Shepro D., Hechtman H.B. Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg. 78:1991;651-655.
6. Hart J.L., Sobey C.G., Woodman O.L. Cholesterol feeding enhances vasoconstrictor effects of products from rabbit polymorphonuclear leukocytes. Am J Physiol. 269:1995;H1-H6.
7. Sobey C.G., Dusting G.J., Stewart A.G., Woodman O.L. Rabbit polymorphonuclear leukocytes cause endothelium-dependent contraction of rabbit aorta. J Vasc Med Biol. 2:1990;107-115.
8. Sobey C.G., Dusting G.J., Grossman H.J., Woodman O.L. Impaired vasodilatation of epicardial coronary arteries and resistance vessels following myocardial ischaemia and reperfusion in anaesthetized dogs. Coron Art Dis. 1:1990;363-373.
9. Sobey C.G., Dalipram R.A., Woodman O.L. Allopurinol and amlodipine improve coronary vasodilatation after ischaemia and reperfusion in anaesthetized dogs. Br J Pharmacol. 108:1993;342-347.
10. Mehta J.L., Nichols W.W., Donnelly W.H.et al. Protection by superoxide dismutase from myocardial dysfunction and attenuation of vasodilator reserve after coronary occlusion and reperfusion in dog. Circ Res. 65:1989;1283-1295.
11. Kim Y.D., Fomsgaard J.S., Heim K.F.et al. Brief ischaemia-reperfusion induces stunning of endothelium in canine coronary artery. Circulation. 85:1992;1473-1482.
12. Sobey C.G., Dalipram R.A., Dusting G.J., Woodman O.L. Impaired endothelium-dependent relaxation of dog coronary arteries after myocardial ischaemia and reperfusion: prevention by amlodipine, propranolol and allopurinol. Br J Pharmacol. 105:1992;557-562.
13. Loke K.E., Woodman O.L. Effect of ischaemic preconditioning on vascular dysfunction induced by ischaemia and reperfusion in rat hindquarters. Cardiovasc Res. 32:1996;1081-1087.
14. Pannangpetch P., Woodman O.L. The effect of ischaemia on endothelium-dependent vasodilatation and adrenoceptor-mediated vasoconstriction in rat isolated hearts. Br J Pharmacol. 117:1996;1047-1052.
15. Hearse D.J., Maxwell L., Saldanha C., Gavin J.B. The myocardial vasculature during ischemia and reperfusion: a target for injury and protection. J Mol Cell Cardiol. 25:1993;759-800.
16. Engler R. Granulocytes and oxidative injury in myocardial ischemia and reperfusion. Fed Proc. 46:1987;2395-2396.
17. Ma X., Tsao P., Viehman G., Lefer A. Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery. Circ Res. 69:1991;95-106.
18. Ohlstein E.H., Nichols A.J. Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Circ Res. 65:1989;917-924.
19. Sobey C.G., Dusting G.J., Stewart A.G. Tumour necrosis factor_α augments the release of an endothelium-dependent vasoconstrictor from human polymorphonuclear leukocytes. J Cardiovasc Pharmacol. 20:1992;813-819.
20. Sheridan F.M., Dauber I.M., McMurtry I.F., Lesnefsky E.J., Horwitz L.D. Role of leukocytes in coronary vascular endothelial injury due to ischemia and reperfusion. Circ Res. 69:1991;1566-1574.
21. Ma X.-L., Lefer D.J., Lefer A.M., Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation. 86:1992;937-946.
22. Lefer D.J., Nakanishi K., Johnston W.E., Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischaemia and reperfusion in dogs. Circulation. 88:1993;2337-2350.
23. Siegfried M.S., Erhardt J., Rider T., Ma X.-L., Lefer A.M. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther. 260:1992;668-675.
24. Lefer D.J., Nakanishi K., Vinten-Johansen J. Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion. J Cardiovasc Pharmacol. 22(Suppl 7):1993;S34-S43.
25. Pabla R., Buda A.J., Flynn D.M., Blesse S.A., Shin A.M., Curtis M.J., Lefer D.J. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res. 78:1996;65-72.
26. Gaviraghi G., Micheli D., Trist D.G. Recent developments in the use of calcium antagonists in myocardial protection. Pharm Res. 31:1995;251-254.
27. Burges R.A. The pharmacological profile of amlodipine in relation to ischaemic heart disease. Postgrad Med J. 67(Suppl 3):1991;S9-S15.
28. Kloner R.A., Przylenk K. Progress in cardioprotection: the role of calcium antagonists. Am J Cardiol. 66:1990;2H-9H.
29. 2+ antagonist nifedipine on the release of platelet activating factor (PAF-acether), slow reacting substance and β-glucuronidase from human neutrophils. Eur J Pharmacol. 89:1983;19-26.
30. Irita K., Fujita I., Takeshigi K., Minakami S., Yoshitake J. Calcium channel antagonist induced inhibition of superoxide production in human neutrophils. Mechanisms independent of antagonizing calcium influx. Biochem Pharmacol. 35:1986;3465-3471.
31. McDonagh P.F., Rauzzino M.J. Stimulated leukocyte adhesion in coronary microcirculation is reduced by a calcium antagonist. Am J Physiol. 265:1993;H476-H483.
32. Pasternak RC, Braunwald E, Sobel BE. Acute myocardial infarction. In: E Braunwald, editor. Heart disease: a textbook of cardiovascular medicine. Philadelphia: Saunders, 1988:1222-1313.
33. Braunwald E, Sobel BE. Coronary blood flow and myocardial ischaemia. In: E Braunwald, editor. Heart disease: a textbook of cardiovascular medicine. Philadelphia: Saunders, 1988:1191-1221.
34. Sakuma I., Togashi H., Yoshioka M.et al. NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo: A role for nitric oxide in the central regulation of sympathetic tone? Circ Res. 70:1992;607-611.